全球中风管理市场规模、份额和成长分析：按诊断、按最终用户 - 产业预测（2023-2030）

Global Stroke Management Market Size, Share, Growth Analysis, By Diagnosis(Imaging, blood tests), By End user (Hospitals, clinics) - Industry Forecast 2023-2030

出版日期: 2023年09月21日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球卒中管理市场规模预计到 2023 年将达到 151.1 亿美元，到 2030 年将达到 331.9 亿美元，在预测期内（2023-2030 年）年复合成长率为 11.9%。

高龄化和中风风险意识不断增强等要素正在推动市场成长。远端医疗和影像领域的技术创新有助于改善诊断和治疗方法。总体而言，市场专注于整体中风管理，以实现最佳患者福祉，包括急性介入、復健支持和长期管理。

促进因素

市场成长促进因素包括增加对医疗基础设施的投资、对创新技术和远端医疗选择的接受程度不断提高。这些趋势支持中风的早期发现和有效干预，从而改善患者的治疗结果和健康。

抑制因素

无障碍挑战

某些地区的认识有限、治疗成本上升以及中风管理技术与当前医疗保健系统难以协调，市场成长受到阻碍，所有这些都限制了市场扩张的全部潜力。

市场趋势

近年来，市场取得了显着进步。远端医疗和数数位健康解决方案的进步促进了远端监控和快速介入。 MRI 和 CT 扫描等最先进的影像方法正在提高诊断准确性。包括血管内血栓切除术在内的微创外科手术彻底改变了急性中风的治疗方法。此外，製药创新带来了更有效的溶栓药物和神经保护疗法。此外，联合研究和公众意识活动强调早期发现和降低风险的重要性。这些累积的进步旨在加强中风预防、及时治疗和长期康復，最终将改善患者的治疗结果并减轻全球中风负担。

本报告研究分析全球中风管理市场，提供市场动态与预测、細項分析、公司简介等。

Medtronic (United States)
Stryker Corporation (United States)
Bayer AG (Germany)
Boston Scientific Corporation (United States)
Johnson & Johnson (United States)
Abbott Laboratories (United States)
Penumbra, Inc. (United States)
MicroPort Scientific Corporation (China)
Terumo Corporation (Japan)
Koninklijke Philips NV (Netherlands)
GE Healthcare (United Kingdom)
Siemens Healthineers AG (Germany)
Nihon Kohden Corporation (Japan)
Acandis GmbH (Germany)
Penumbra, Inc. (United States)
Balt Extrusion (France)
Olympus Corporation (Japan)
Integra LifeSciences Holdings Corporation (United States)
Merit Medical Systems, Inc. (United States)
Sirtex Medical Limited (Australia)

简介目录

Product Code: SQMIG35A2508

Market Insights

Global Stroke Management Market size was valued at USD 37 billion in 2022 and is poised to grow from USD 15.11 billion in 2023 to USD 33.19 billion by 2030, at a CAGR of 11.9% during the forecast period (2023-2030).

The Global Stroke Management Market encompasses a range of medical solutions and interventions aimed at preventing, diagnosing, and treating strokes. This market involves pharmaceuticals, medical devices, and rehabilitation services, all designed to enhance patient outcomes and quality of life. Factors such as aging populations and increased awareness of stroke risks drive market growth. Innovations in telemedicine and neuroimaging contribute to improved diagnostic and treatment approaches. Overall, the market focuses on holistic stroke care, including acute intervention, recovery support, and long-term management for optimal patient well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of stroke management and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global stroke management market can be segmented based on diagnosis, region, and end-users. Diagnosis includes imaging, blood tests, and physical examination. End-users encompass of hospitals, clinics, and ambulatory surgical centers. Based on region, the market is segmented into North America, Latin America, Asia Pacific, Europe, and MEA.

Drivers

Factors driving the growth of the global stroke management market include the rising investment in healthcare infrastructure and the growing acceptance of innovative technologies and telemedicine options. These trends are boosting early detection and effective intervention for strokes, leading to enhanced patient results and well-being.

Restraints

Accessibility Challenges:

The growth of the worldwide stroke management market is impeded by restricted awareness in specific areas, elevated treatment expenses, and difficulties in harmonizing stroke management technologies with prevailing healthcare systems, all of which curtail its complete potential for expansion.

Market Trends

In recent times, significant progress has been observed within the global stroke management market. Advances in telemedicine and digital healthcare solutions have facilitated remote monitoring and prompt intervention. Cutting-edge neuroimaging methods like MRI and CT scans have elevated the accuracy of diagnoses. Minimally invasive surgical procedures, including endovascular thrombectomy, have brought about a revolution in the treatment of acute strokes. Furthermore, innovations in pharmaceuticals have yielded more efficient clot-dissolving medications and neuroprotective therapies. Collaborative research endeavors and public awareness initiatives have underscored the significance of early detection and risk mitigation. These collective advancements aim to enrich stroke prevention, immediate care, and prolonged rehabilitation, thereby ultimately enhancing patient outcomes and diminishing the global stroke burden.